Profile
SV Health Investors is a healthcare and life sciences investor based in Boston and London. Established over 30 years ago, the firm comprises a team of more than 50 investment professionals and operating partners, bringing together experienced investors and healthcare industry veterans. What sets SV Health apart is its focus on transformational healthcare investments across biotechnology, healthcare growth, and medical devices, coupled with a commitment to supporting diverse entrepreneurs in their ventures.
SV Health Investors actively invests in sectors including therapeutics, medtech, and healthcare growth, with particular focus on companies that aim to innovate and transform medical treatments and healthcare industry processes. The firm has over $4.0 billion in historical commitments and operates multiple specialized funds such as the SV8 Biotech Fund and Dementia Discovery Fund. Geographically, their investment reach spans the US and UK.
Notable portfolio companies include American Well - telehealth services, Ximedica - medical device development, and Evidation Health - data analytics in healthcare. SV Health Investors has facilitated over 75 IPOs and M&As, highlighting their strategic focus on companies that attract public and strategic investors.
Industry
SV Health Investors Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
SV7 Health Impact Fund
|
Fund of funds
|
Biotechnology
Healthcare Services
Pharmaceuticals
|
Seed
Series A
Series B
|
North America
Europe
|
$5-10 m
|
$250 M
|
July 2019
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.